Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Worek

Showing results (201-210 of 226) with videos related to

Pageof 23
Sort By:
Archives of Toxicology|December 28, 2021
Post-VX exposure treatment of rats with engineered phosphotriesterasesLisa Stigler, Anja Köhler, Marianne Koller, et al.
Toxicology Letters|November 4, 2017
Searching for putative binding sites of the bispyridinium compound MB327 in the nicotinic acetylcholine receptorThomas Wein, Georg Höfner, Sebastian Rappenglück, et al.
Plos One|December 15, 2010
Nanoparticulate transport of oximes over an in vitro blood-brain barrier modelSylvia Wagner, Jürgen Kufleitner, Anja Zensi, et al.
Organic & Biomolecular Chemistry|March 5, 2011
Optimized strategies to synthesize β-cyclodextrin-oxime conjugates as a new generation of organophosphate scavengersRomain Le Provost, Timo Wille, Ludivine Louise, et al.
Toxicology Letters|September 9, 2014
Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept studyFranz Worek, Thomas Seeger, Georg Reiter, et al.
The Biochemical Journal|April 17, 2009
Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabunEugénie Carletti, Nadine Aurbek, Emilie Gillon, et al.
Chemmedchem|October 27, 2018
Synthesis of a Series of Non-Symmetric Bispyridinium and Related Compounds and Their Affinity Characterization at the Nicotinic Acetylcholine ReceptorSebastian Rappenglück, Sonja Sichler, Georg Höfner, et al.
Chemmedchem|July 6, 2018
Synthesis of a Series of Structurally Diverse MB327 Derivatives and Their Affinity Characterization at the Nicotinic Acetylcholine ReceptorSebastian Rappenglück, Sonja Sichler, Georg Höfner, et al.
Plos One|March 8, 2012
Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier modelSylvia Wagner, Anja Zensi, Sascha L Wien, et al.
Toxicology Letters|December 4, 2012
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: evaluation of the detoxification using a half-quantitative enzymatic assayRaman Kumar Kalakuntla, Timo Wille, Romain Le Provost, et al.
Pageof 23

Showing results (201-210 of 226) with videos related to

Sort By:
Pageof 23
Archives of Toxicology|December 28, 2021
Post-VX exposure treatment of rats with engineered phosphotriesterasesLisa Stigler, Anja Köhler, Marianne Koller, et al.
Toxicology Letters|November 4, 2017
Searching for putative binding sites of the bispyridinium compound MB327 in the nicotinic acetylcholine receptorThomas Wein, Georg Höfner, Sebastian Rappenglück, et al.
Plos One|December 15, 2010
Nanoparticulate transport of oximes over an in vitro blood-brain barrier modelSylvia Wagner, Jürgen Kufleitner, Anja Zensi, et al.
Organic & Biomolecular Chemistry|March 5, 2011
Optimized strategies to synthesize β-cyclodextrin-oxime conjugates as a new generation of organophosphate scavengersRomain Le Provost, Timo Wille, Ludivine Louise, et al.
Toxicology Letters|September 9, 2014
Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept studyFranz Worek, Thomas Seeger, Georg Reiter, et al.
The Biochemical Journal|April 17, 2009
Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabunEugénie Carletti, Nadine Aurbek, Emilie Gillon, et al.
Chemmedchem|October 27, 2018
Synthesis of a Series of Non-Symmetric Bispyridinium and Related Compounds and Their Affinity Characterization at the Nicotinic Acetylcholine ReceptorSebastian Rappenglück, Sonja Sichler, Georg Höfner, et al.
Chemmedchem|July 6, 2018
Synthesis of a Series of Structurally Diverse MB327 Derivatives and Their Affinity Characterization at the Nicotinic Acetylcholine ReceptorSebastian Rappenglück, Sonja Sichler, Georg Höfner, et al.
Plos One|March 8, 2012
Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier modelSylvia Wagner, Anja Zensi, Sascha L Wien, et al.
Toxicology Letters|December 4, 2012
New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: evaluation of the detoxification using a half-quantitative enzymatic assayRaman Kumar Kalakuntla, Timo Wille, Romain Le Provost, et al.
Pageof 23